|
Aug 8
|
3 Stocks That May Be Trading Below Estimated Value In August 2025
|
|
Aug 8
|
Ligand Pharmaceuticals Among 3 Stocks Possibly Trading Below Intrinsic Value Estimates
|
|
Aug 7
|
Ligand: Q2 Earnings Snapshot
|
|
Aug 7
|
Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
|
|
Aug 5
|
Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings
|
|
Jul 31
|
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
|
|
Jul 24
|
Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025
|
|
Jul 17
|
Ligand Pharmaceuticals Stock Earns 84 RS Rating
|
|
Jul 16
|
3 Stocks That Might Be Undervalued And Present An Investment Opportunity
|
|
Jul 16
|
First Solar And 2 Additional Stocks That May Be Priced Below Estimated Value
|
|
Jul 14
|
3 Stocks That May Be Trading Below Estimated Value In July 2025
|
|
Jul 14
|
3 Stocks Estimated To Be Trading At A Discount Of Up To 25.8%
|
|
Jun 17
|
Incyte And Two Other Stocks That May Be Priced Below Their Estimated Value
|
|
May 14
|
Ligand to Ring the Nasdaq Opening Bell on May 19, 2025
|
|
May 12
|
LGND: 1Q:25 Results
|
|
May 11
|
Ligand Pharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Feb 13
|
Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
|
|
Oct 9
|
Ligand Pharmaceuticals Inc (LGND) Q2 2024 Earnings Call Highlights: Robust Revenue Growth Amid ...
|
|
Oct 9
|
LGND: Initiating Coverage – A Prince Among Royalty
|
|
Jul 23
|
Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
|